Effect of Early Treatment with Ivermectin among Patients with

$ 27.00

4.6 (368) In stock

Ivermectin is ineffective in non-severe COVID-19 patients according to new study

Frontiers Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial

Frontiers Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial

Small molecules in the treatment of COVID-19

Ivermectin cures parasites in cows, not COVID-19 in humans - University of Mississippi Medical Center

Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial

Viruses, Free Full-Text

COVID OUT clinical trial suggests metformin effective at reducing odds of serious outcomes for COVID-19 patients seeking early treatment

Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype, BMC Infectious Diseases

Results of a systematic review and meta-analysis of early studies on ivermectin in SARS-CoV-2 infection

Pharmaceutics, Free Full-Text

Biologics, Free Full-Text

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial, BMC Infectious Diseases

Eric Topol on X: Ivermectin: the largest randomized, double-blind trial yet conducted, with early treatment, indicates there is no difference compared with placebo. It doesn't work. Period. just published @NEJM